Dr. Robert Brookins
Chief Executive Officer
Robert (Bob) Brookins, Ph.D., M.A.E. B.A. B.Sc is the Chief Executive Officer. Dr. Brookins has experience in organic synthesis, materials chemistry, and chem/bio decontamination. He received his Ph.D. from the University of Florida in the areas of synthesis and characterization of conjugated poly-electrolytes and polymers with an emphasis on developing new polymerization methods. Upon completion of his Ph.D., he worked at the US Air Force Research Laboratory at Tyndall AFB, FL where he developed decontamination methods for chemical and biological threats and developed novel synthetic routes for reactive and functional surfaces.
Chief Financial Officer
Over the past 22 years, Jason Lewis has worked with ArrMaz, a global specialty chemical company in mining, fertilizer, phosphate, asphalt and oil and gas industries. For the past six years, Lewis has held the position of Vice President of Finance. He joined the company in a senior accounting role with cross-departmental work for sales, marketing and operations groups for seven years. Lewis has a strong track record of value creation by way of revenue growth through pricing, long-term customer contracts, cost optimization through analysis tools, negotiation of services, department restructuring, debt management and working capital reduction through controls and process improvements. He also has strong international experience including greenfield start-ups.
Chief Commercial Officer
Prior to joining Alexium, Allen Reihman worked for nine years at Invista, the world’s largest integrated fiber, resin, and intermediates company. As Director of New Business Development, Reihman was the entrepreneur for the successful commercialization of new specialty polymers. He led all phases of this innovation program, including product development, manufacturing, intellectual property, pricing strategies, branding, business planning, and strategic alliances. Additionally, Reihman served as Director of Commercial Development for five global specialty chemical businesses at Invista where he led growth initiatives, valuation and decision analysis, market research, and strategy development. Previously, Reihman worked for seven years at Eastman Chemical where he held a range of commercial leadership roles in corporate development, global P&L general management, innovation, and market development.
Board of Directors
Rosheen Garnon (BEc (Accounting major), LLB, FCA, CTA, GAICD) has had a distinguished career in the accounting profession as a chartered accountant and taxation advisor. She was a senior partner with KPMG and held senior executive leadership roles with the Firm in Australia and at a global level. Garnon was a member of the KPMG Australian Executive Leadership Team for six years as the National Managing Partner for a significant client services division. She has extensive experience of working with Boards and C-Suite executives.
Garnon started her career with Peat Marwick Mitchell & Co (a predecessor firm of KPMG) in 1987 and was made partner in July 2000. She has extensive experience working with multinational organisations particularly in the mining, oil &gas, and defense industries. Garnon’s prominence in the accounting profession was recently recognized in her appointment to the Board of Taxation, an Independent Advisory Board, that advises the Federal Treasurer and Assistant Treasurer on Australia’s Taxation Policy.
Brig. Gen. Stephen Cheney, USMC (Ret).
General Stephen Cheney was a decorated Marine and is the former Inspector General of the Marine Corps and Commanding General of Parris Island Marine Base. He was appointed on April 15, 2015 to Alexium’s board. He is also the former Deputy Executive Secretary to U.S. Defense Secretary Dick Cheney and was also a member of Secretary of State John Kerry’s Foreign Affairs Policy Board. General Cheney serves as the chairman of Alexium’s Remuneration Committee.
Claire Poll is an experienced corporate director having led, over the past 20 years, strategy and corporate development for startup technology companies through to large multi-billion dollar companies in Australia, the UK and more recently the US as a Founding Executive for the October listing of Verona Pharma plc (Nasdaq:VRNA) for which Poll “rang the bell”. Poll, who originally qualified as a solicitor in Western Australia, has worked as a Director, general counsel and as a company secretary in public listed companies in the US, UK and Australia in the areas of venture capital, mobile satellite communications, internet services, software and biopharmaceuticals. Poll, who is based in Perth WA, started her corporate career with Burns Philp Company Limited, the diversified global company involved in food manufacturing, shipping and general trading. Poll also holds a post graduate diploma in Applied Corporate Finance, M&A and Advanced Industrial Equity Analysis.
Vice President, Investor Relations
Mark Wise possesses more than 30 years of experience in investment markets and previously was a Portfolio Manager in New York, where he managed portfolios of Asian and Australian equities. Wise earned a Bachelor of Commerce degree with a focus in Accounting and Finance from the University of New South Wales in Sydney, Australia.
We have offices in the US and Australia with distributors world-wide
2018 Corporate Governance and Directory
Alexium International Group Limited (“Company”) has adopted comprehensive systems of control and accountability as the basis for the administration of corporate governance. The Board of the Company is committed to administering the policies and procedures with openness and integrity, pursuing the true spirit of corporate governance commensurate with the Company’s needs.
To the extent they are applicable to the Company, the Board has adopted the Eight Corporate Governance Principles and Recommendations as published by ASX Corporate Governance Council (“ASX Corporate Governance Principles and Recommendations”).
The Company is pleased to make the following information on its corporate governance practices available below.